Abstract:Abstract Background Low-grade glioma (LGG) is susceptible to ferroptosis, which is involved in TMZ resistance. Ferroptosis induction can enhance the sensitivity to TMZ and synergistically kill glioma cells. T cell-promoted tumor ferroptosis is a vital anti-tumor mechanism of immune checkpoint inhibitors. The SAT1 activation is closely related to ferroptosis upon ROS induction due to the upregulation of arachidonate 15-lipoxygenase (ALOX15) expression. Methods The expression of SAT1 in pan-cancer and corresponding normal tissue from the TCGA data portal was primarily explored. The landscape of SAT1 and immune cell infiltration and their corresponding gene marker sets in different tissues were further explored. Additionally, we evaluated the relationships between SAT1 and the clinicopathologic parameters of LGG, and the disease-specific survival (DSS), progression-free interval (PFI), and overall survival (OS) were also assessed using KM survival curves and multivariate analysis in LGG. Meanwhile, the Gene Set Enrichment Analysis (GSEA) was also implemented to determine the potential effect of the SAT1 gene in LGG. Furthermore, the predictive power of SAT1 was validated using an independent LGG cohort from the Chinese Glioma Genome Atlas (CGGA) data. Results In general, the expression of SAT1 is different between most tumors and their adjacent normal tissues. The results demonstrated that SAT1 expression is positively associated with TMB in LGG, BRCA, and THYM. The results displayed that the expression level of SAT1 is obviously correlated with the level of infiltrating macrophages and CD8 + T cells, and the levels of most immune gene sets were associated with the SAT1 expression in LGG. Interestingly, univariate and multivariate models significantly indicated that the OS and PFI of patients with LGG with high SAT1 levels were poorer than those with low SAT1 expression in the TCGA LGG cohort. GSEA showed that SAT1 was involved in immune regulation and multiple signaling pathways. Finally, our analysis demonstrated that SAT1 was closely associated with IDH mutation, 1p19q codeletion, chemoradiotherapy resistance and disease recurrence. Conclusions Abundant expression of SAT1 was related to poor disease prognosis and abundant immune cell infiltration in LGG.

LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway

Effect of Inhibiting LITAF Expression on Proliferation, Apoptosis and Radiosensitivity of Human Glioblastoma U251 Cell

[Significance of Expression and Promoter Methylation of LITAF Gene in B-cell Lymphoma].

LRIG 1 Enhances the Radiosensitivity of Radioresistant Human Glioblastoma U 251 Cells Via Attenuation of the EGFR / Akt Signaling Pathway

HIF1A-dependent Overexpression of MTFP1 Promotes Lung Squamous Cell Carcinoma Development by Activating the Glycolysis Pathway

C-Fos Over-Expression Promotes Radioresistance and Predicts Poor Prognosis in Malignant Glioma

LITAF is a potential tumor suppressor in pancreatic cancer

LTF as a Potential Prognostic and Immunological Biomarker in Glioblastoma

miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation

Silencing of FOXG1 confers radio-sensitivity through regulating autophagy in glioma cells

FOXG1 Mediates the Radiosensitivity of Glioma Cells Through Regulation of Autophagy.

Suppression of FoxO3a Increases Responsiveness of Glioma Cells to Radiation Treatment

LTF Induces Radioresistance by Promoting Autophagy and Forms an AMPK/SP2/NEAT1/miR-214-5p Feedback Loop in Lung Squamous Cell Carcinoma

Inhibition of Cathepsin L Sensitizes Human Glioma Cells to Ionizing Radiation in Vitro Through NF-κB Signaling Pathway

TIFA enhances glycolysis through E2F1 and promotes the progression of glioma

Lipopolysaccharide-induced Tumor Necrosis Factor-Α Factor Enhances Inflammation and is Associated with Cancer (Review).

Upregulated AHIF-mediated Radioresistance in Glioblastoma.

Hypoxia Induced Ferritin Light Chain (FTL) Promoted Epithelia Mesenchymal Transition and Chemoresistance of Glioma

Upregulation of LGMNP1 Confers Radiotherapy Resistance in Glioblastoma.

LncRNA LUCAT1 Promotes Glioblastoma Progression by Enhancing HIF1α Activity

Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma